Relative cost of etanercept versus infliximab in the treatment of rheumatoid arthritis.

被引：0
作者：
Sweis, BP
Ellman, CJ
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Univ Jordan, Amman, Jordan
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
[21]   Cost minimization analysis of rituximab versus infliximab, adalimumab and etanercept for rheumatoid arthritis from a payer perspective in Brazil [J].
Saggia, M. G. ;
Santos, E. A. ;
Nasciben, V .
VALUE IN HEALTH, 2007, 10 (06) :A247-A247
[22]   Enbrel® (etanercept) pharmacokinetics in patients with rheumatoid arthritis. [J].
Kremer, JM ;
Spencer-Green, GT ;
Hanna, RK ;
Korth-Bradley, JM .
ARTHRITIS AND RHEUMATISM, 2000, 43 (09) :S229-S229
[23]   Etanercept in children with polyarticular juvenile rheumatoid arthritis. [J].
Lovell, DJ ;
Giannini, EH ;
Reiff, A ;
Cawkwell, GD ;
Silverman, ED ;
Nocton, JJ ;
Stein, LD ;
Gedalia, A ;
Ilowite, NT ;
Wallace, CA ;
Whitmore, J ;
Finck, BK .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (11) :763-769
[24]   ETANERCEPT ORIGINATOR VERSUS ITS BIOSIMILAR (SB4) FOR THE TREATMENT OF RHEUMATOID ARTHRITIS. ARE THEY TRULY SIMILAR? [J].
Rokad, Aasiyah ;
Kearsley-Fleet, Lianne ;
Watson, Kath ;
Lunt, Mark ;
Hyrich, Kimme L. .
RHEUMATOLOGY, 2022, 61 :I8-I8
[25]   A cost-efficacy analysis of etanercept and infliximab in the treatment of psoriatic arthritis [J].
Yu, EB ;
Woolley, JM .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 :400-400
[26]   The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis [J].
Vergel, Y. Bravo ;
Hawkins, N. S. ;
Claxton, K. ;
Asseburg, C. ;
Palmer, S. ;
Woolacott, N. ;
Bruce, I. N. ;
Sculpher, M. J. .
RHEUMATOLOGY, 2007, 46 (11) :1729-1735
[27]   Etanercept versus infliximab plus methotrexate in rheumatoid arthritis: A cost-effectiveness analysis from the Italian NHS perspective [J].
Lopatriello, S ;
Berto, P .
VALUE IN HEALTH, 2003, 6 (06) :725-725
[28]   Cost of Etanercept, Adalimumab, and Infliximab in Patients with Rheumatoid Arthritis with Employer Provided Health Insurance [J].
Bonafede, Machaon ;
Watson, Crystal ;
Joseph, George ;
Princic, Nicole ;
Harrison, David J. .
ARTHRITIS AND RHEUMATISM, 2012, 64 (10) :S778-S778
[29]   The cost of glucocorticoids in rheumatoid arthritis. [J].
Pisu, M ;
James, NT ;
Saag, KG .
ARTHRITIS AND RHEUMATISM, 2002, 46 (09) :S167-S167
[30]   Cost-effectiveness of low dose corticosteroids versus nsaids in the treatment of rheumatoid arthritis. [J].
Bae, SC ;
Corzillius, M ;
Kuntz, KM ;
Liang, MH .
ARTHRITIS AND RHEUMATISM, 1998, 41 (09) :S249-S249
12345